Genetically determined brain abnormalities in Down’s Syndrome.- towards a treatment: A randomised, single-blind, placebo-controlled trial of lithium carbonate in Down’s Syndrome (DownsLit). - Downs Syndrome Lithium Trial (DownsLit)

King's College London0 个研究点目标入组 34 人开始时间: 2009年7月9日最近更新: 2018年12月4日

试验速览

暂无简介。

•Individuals with Down Syndrome
•Over the age of 18 years
•Able to provide informed consent or have a legal representative to consent on their behalf if they lack capacity
•Able to communicate with the investigator and to comply with requirements of the study
•Has carer support
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 34
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•Individuals with contraindications to lithium treatment
•Individuals with contraindications to undergoing a magnetic resonance scan
•Non-compliance with taking of the tablets between baseline and the 4-week assessment
•Treatment with lithium within the last 6 months
•Evidence of dementia

发起方